XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
8. Stock Based Compensation (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Restricted stock outstanding
    Shares     Weighted average grant date price  
Non-vested, December 31, 2019     255,634     $ 7.18  
Granted     97,570       6.60  
Forfeited     (1,954 )     6.92  
Vested     (62,777 )     6.34  
Non-vested, September 30, 2020     288,473       7.97  
Stock options outstanding
    Number of shares underlying options     Weighted average exercise price per share     Weighted average grant date fair value  
Outstanding, December 31, 2019     29,165     $ 7.20     $ 3.76  
Forfeited     (12,083 )     8.76       4.34  
Outstanding, September 30, 2020     17,082       6.10       3.36  
Nonvested stock options outstanding
    Number of shares underlying options     Weighted average exercise price per share     Weighted average grant date fair value  
Non-vested, December 31, 2019     5,416     $ 5.48     $ 3.01  
Vested     (3,228 )     5.47       2.98  
Non-vested, September 30, 2020     2,188       5.50       3.05  
Intrinsic value
    Number of shares underlying options     Weighted average exercise price per share      Weighted average remaining contractual life (years)      Aggregate intrinsic value  
Outstanding     17,082     $ 6.10       5.92     $ 39,703  
Exercisable     14,894       6.18       5.66       23,053